DURECT CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.59 EUR | +31.40% |
|
+36.21% | +200.95% |
| 21/05 | DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis | CI |
| 21/05 | Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 53.07M | - | - | - | |||
| 118B | ||||||
| 106B | ||||||
| 24.28B | - | |||||
| 21.96B | - | |||||
| 18.16B |
